Company / Interest Expense
Opus Genetics, Inc. Interest Expense History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$9.0K
FY2023
5-year range
$2.0K / $6.8M
FY2021-FY2023
Trend
+350.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense changed +350% YoY in FY2023, a notable deviation from the 2-year average annual change of +125%.
Based on SEC 10-K filings.
$9,000 in FY2023.
Improved from $7M to $9,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, interest expense increased 350.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $9.0K | +350.0% |
| FY2022 | $2.0K | -100.0% |
| FY2021 | $6.8M | - |
| FY2013 | - | - |
| FY2011 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026